- Telehealth Visits
- Insurance plan information
Katerina Melino, NP
She | Her | HersHIV Medicine • Psychiatry- Telehealth Visits
- Insurance plan information
Katerina Melino, NP
She | Her | HersHIV Medicine • Psychiatry- Telehealth Visits
- Insurance plan information
On this page
About me
Katerina Melino, who goes by Kate, is a mental health nurse practitioner who cares for men living with HIV. She has special interests in the integration of primary and behavioral health care, concurrent treatment of mental health and substance use disorders, geriatric psychiatry and LGBTQ mental health. She also has special training to provide medication-assisted treatment for opioid use disorder.
Areas of Melino's research include mental health, substance use, trauma-informed care and graduate nursing education.
Melino earned her bachelor's degree in nursing from the University of Toronto. She earned her master's degree in nursing, specializing in psychiatric mental health, at UCSF. She has experience working in many parts of the U.S. and other countries as a psychiatric provider of all types of mental health services, and has served in both clinical and administrative leadership roles.
Melino is a member of the American Psychiatric Nurses Association and National Organization of Nurse Practitioner Faculties.
Education & training
Board certification
- Psych-Mental Health NP, American Nurses Credentialing Center
Degree
- Nurseph, University of Alberta
- MS, UCSF School of Nursing
My expertise
Clinical Trials query: q=health_gateway_id_ss%3A%28%223183%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223183%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.